Insiders · Profile

Chodakewitz Jeffrey

EVP GMDA, CMO at Vertex Pharmaceuticals. Filing since 7 Oct 2014. CIK 0001610876

Company

Date

Role

Action

Shares

Amount

Of holding

VRTX Vertex Pharmaceuticals

12 Feb 2018

EVP GMDA, CMO

Sold, plan not stated

5,122

$772.49K

6.8%

VRTX Vertex Pharmaceuticals

5 Feb 2018

EVP GMDA, CMO

Sold, plan not stated

3,594

$580.30K

6.4%

VRTX Vertex Pharmaceuticals

2 Feb 2018

EVP GMDA, CMO

Sold, plan not stated

1,796

$298.33K

3.3%

VRTX Vertex Pharmaceuticals

1 Feb 2018

EVP GMDA, CMO

Sold, plan not stated

1,900

$318.14K

3.5%

VRTX Vertex Pharmaceuticals

16 Jan 2018

EVP GMDA, CMO

Sold, plan not stated

1,719

$270.36K

3.1%

VRTX Vertex Pharmaceuticals

2 Jan 2018

EVP GMDA, CMO

Sold, plan not stated

3,438

$521.89K

5.9%

VRTX Vertex Pharmaceuticals

3 Nov 2017

EVP GMDA, CMO

Sold, plan not stated

3,594

$520.02K

6.2%

VRTX Vertex Pharmaceuticals

2 Nov 2017

EVP GMDA, CMO

Sold, plan not stated

1,796

$259.98K

3.2%

VRTX Vertex Pharmaceuticals

31 Oct 2017

EVP GMDA, CMO

Sold, plan not stated

60,000

$8.70M

52.4%

VRTX Vertex Pharmaceuticals

16 Oct 2017

EVP GMDA, CMO

Sold, plan not stated

1,718

$266.61K

1.5%

VRTX Vertex Pharmaceuticals

2 Oct 2017

EVP GMDA, CMO

Sold, plan not stated

3,437

$521.20K

2.9%

VRTX Vertex Pharmaceuticals

3 Aug 2017

EVP GMDA, CMO

Sold, plan not stated

3,594

$554.15K

3.0%

VRTX Vertex Pharmaceuticals

2 Aug 2017

EVP GMDA, CMO

Sold, plan not stated

1,796

$276.81K

1.5%

VRTX Vertex Pharmaceuticals

21 Jul 2017

EVP GMDA, CMO

Sold, plan not stated

6,900

$1.11M

5.7%

VRTX Vertex Pharmaceuticals

19 Jul 2017

EVP GMDA, CMO

Sold, plan not stated

39,833

$6.41M

24.7%

VRTX Vertex Pharmaceuticals

17 Jul 2017

EVP GMDA, CMO

Sold, plan not stated

573

$74.40K

0.5%

VRTX Vertex Pharmaceuticals

3 Jul 2017

EVP GMDA, CMO

Sold, plan not stated

3,438

$439.38K

2.7%

VRTX Vertex Pharmaceuticals

21 Jun 2017

EVP GMDA, CMO

Sold, plan not stated

5,157

$685.21K

4.0%

VRTX Vertex Pharmaceuticals

1 Jun 2017

EVP GMDA, CMO

Sold, plan not stated

5,155

$654.01K

4.0%

VRTX Vertex Pharmaceuticals

2 May 2017

EVP GMDA, CMO

Sold, plan not stated

8,979

$1.09M

6.8%

VRTX Vertex Pharmaceuticals

5 Apr 2017

EVP GMDA, CMO

Sold, plan not stated

8,021

$914.39K

6.1%

VRTX Vertex Pharmaceuticals

3 Apr 2017

EVP GMDA, CMO

Sold, plan not stated

2,291

$249.38K

1.8%

VRTX Vertex Pharmaceuticals

29 Mar 2017

EVP GMDA, CMO

Sold, plan not stated

13,750

$1.47M

10.1%

VRTX Vertex Pharmaceuticals

13 Feb 2017

EVP GMDA, CMO

Sold, plan not stated

5,122

$449.05K

4.0%

VRTX Vertex Pharmaceuticals

1 Feb 2017

EVP GMDA, CMO

Sold, plan not stated

1,900

$162.90K

1.7%

VRTX Vertex Pharmaceuticals

2 Feb 2016

EVP GMDA, CMO

Sold, plan not stated

2,375

$217.02K

2.1%

VRTX Vertex Pharmaceuticals

18 Nov 2015

EVP GMDA, CMO

Sold, plan not stated

10,315

$1.34M

9.3%

VRTX Vertex Pharmaceuticals

2 Jul 2015

EVP GMDA, CMO

Sold, plan not stated

2,291

$296.36K

2.2%

VRTX Vertex Pharmaceuticals

2 Apr 2015

EVP GMDA, CMO

Sold, plan not stated

2,291

$264.60K

2.2%

VRTX Vertex Pharmaceuticals

2 Feb 2015

EVP GMDA, CMO

Sold, plan not stated

1,188

$130.20K

1.4%

VRTX Vertex Pharmaceuticals

2 Jan 2015

EVP GMDA, CMO

Sold, plan not stated

2,291

$280.73K

2.6%

VRTX Vertex Pharmaceuticals

28 Oct 2014

EVP GMDA, CMO

Sold, plan not stated

3,438

$395.37K

26.6%

VRTX Vertex Pharmaceuticals

7 Oct 2014

EVP GMDA, CMO

Sold, plan not stated

3,436

$358.22K

26.6%

33 decisions on file.